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Abstract
Gestational diabetes mellitus increases the risk of dysglycemia postpartum, in part, due
to pancreatic β-cell dysfunction. However, no histological evidence exists comparing
endocrine pancreas after healthy and glucose-intolerant pregnancies. This study
sought to address this knowledge gap, in addition to exploring the contribution of an
inflammatory environment to changes in endocrine pancreas after parturition. We used
a previously established mouse model of gestational glucose intolerance induced by
dietary low protein insult from conception until weaning. Pancreas and adipose samples
were collected at 7, 30 and 90 days postpartum for histomorphometric and cytokine
analyses, respectively. Glucose tolerance tests were performed prior to euthanasia and
blood was collected via cardiac puncture. Pregnant female mice born to dams fed a low
protein diet previously shown to develop glucose intolerance at late gestation relative
to controls continued to be glucose intolerant until 1 month postpartum. However,
glucose tolerance normalized by 3 months postpartum. Glucose intolerance at 7 days
postpartum was associated with lower beta- and alpha-cell fractional areas and higher
adipose levels of pro-inflammatory cytokine, interleukin-6. By 3 months postpartum, a
compensatory increase in the number of small islets and a higher insulin to glucagon
ratio likely enabled euglycemia to be attained in the previously glucose-intolerant
mice. The results show that impairments in endocrine pancreas compensation in
hyperglycemic pregnancy persist after parturition and contribute to prolonged glucose
intolerance. These impairments may increase the susceptibility to development of future
type 2 diabetes.
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Introduction
Pregnancy presents as a unique situation of endocrine
pancreas β-cell adaptation that reverses after parturition.
Late pregnancy is characterized by a state of peripheral
maternal insulin resistance mediated by placental
hormones (Newbern & Freemark 2011) which is essential
for maintaining trans-placental transport of glucose to
the fetus for optimal development. To compensate for
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insulin resistance, the maternal pancreas responds by
increasing endocrine pancreatic β-cell mass (BCM) to
help maintain euglycemia. An adaptive expansion of
BCM has been documented in both rodents and humans
and is maximal at late gestation (around gestational day
(GD) 18 in rodents) (Van Assche et al. 1978, Parsons
et al. 1992, Sorenson & Brelje 1997, Butler et al. 2010,
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Beamish et al. 2017, Szlapinski et al. 2019). The adaptive
mechanisms of BCM expansion during rodent pregnancy
have been studied extensively and occur, in part, due to
increased β-cell hypertrophy and proliferation, and the
expansion of a β-cell precursor pool, all of which peak
at mid-gestation (Parsons et al. 1992, Rieck & Kaestner
2010, Beamish et al. 2017, Szlapinski et al. 2019). These
changes are mediated by increased levels of hormones
including placental lactogen, prolactin, and estrogen
(Rieck & Kaestner 2010, Newbern & Freemark 2011).
After parturition, progesterone-mediated β-cell apoptosis
increases while proliferation decreases concomitant with
an absence of placental lactogen, returning BCM to prepregnancy levels (Scaglia et al. 1995, Rieck & Kaestner
2010). If BCM expansion is sub-optimal, gestational
diabetes mellitus (GDM) can arise.
GDM is described as diabetes that first appears during
pregnancy and occurs due to insufficient β-cell adaptation
to compensate for insulin resistance in pregnancy. The
incidence of GDM worldwide is around 7–10% of all
pregnancies (Ferrara 2007, Nguyen et al. 2018), although
the incidence will vary depending on the population
characteristics and diagnostic criteria. As more women
enter pregnancy obese or at an older age, the incidence of
GDM is projected to continue to rise (Petra et al. 2019). An
increased incidence of GDM is associated with morbidity
due to adverse fetal outcomes (Garcia-Vargas et al. 2012,
Kim et al. 2012, Mitanchez et al. 2015) and adverse longterm maternal outcomes including an increased risk
of type-2 diabetes mellitus (T2DM) (Heida et al. 2015)
between 3% to 90% (Melchior et al. 2017). Clinical studies
have shown that glucose intolerance after parturition
involves β-cell dysfunction (Buchanan & Xiang 2005,
Retnakaran et al. 2008, Xiang et al. 2010, Molęda et al.
2013) which can occur, in part, due to inflammation and
glucotoxicity-induced oxidative stress in β-cells (Tang
et al. 2007).
Pregnancy can be characterized as a low-grade
inflammatory state where the placenta is a major source
of cytokines that can alter β-cell function (Wedekind &
Belkacemi 2016). For example, studies have postulated
that 94% of the increased serum levels of tumor necrosis
factor (TNF-α) in women during pregnancy results from
placental production (Pantham et al. 2015). The first and
early second trimester is a pro-inflammatory environment
characterized by helper T-cell-1 (Th1) cytokines, such as
TNF-α, interleukin-1β, (IL-1β), and interferon (IFN)-γ,
resulting from implantation and placentation processes
(Wedekind & Belkacemi 2016). The second trimester
is characterized as an anti-inflammatory environment
https://joe.bioscientifica.com
https://doi.org/10.1530/JOE-20-0012
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with Th2 cytokines that permit for fetal growth and
development (Mor et al. 2011). Lastly, the third trimester
is characterized by the recurrence of a pro-inflammatory
environment in preparation for parturition, as
inflammation promotes uterine contractions (Gibbs
et al. 1992). Thus, increased cytokine production occurs
in healthy pregnancies. However, increased activity of
the immune-checkpoint molecule programmed deathligand 1 (PD-L1) and its receptor, PD-1, play a role in the
maintenance of immunological balance between mother
and fetus (Meggyes et al. 2019) and likely protect maternal
β-cells from cytotoxic damage. In healthy pregnancies,
PD-L1 is expressed by syncytiotrophoblast cells of the
placenta in response to pro-inflammatory stimuli and is
increasingly released into the maternal bloodstream as
gestation progresses (Veras et al. 2017). The interaction
between PD-L1 and PD-1 reduces clonal expansion of
pathogenic lymphocytes and their associated cytokine
release (Wang et al. 2008). Therefore, with decreased
lymphocyte expansion, cytokine production is decreased
and β-cells are protected against cytokine-induced
damage. In the context of GDM and persistent glucose
intolerance at postpartum, it is plausible that insufficient
levels of PD-L1 cause maternal β-cells to have greater
susceptibility to cytotoxic damage, which can contribute
to β-cell dysfunction. In GDM pregnancies, the low-grade
inflammation that normally takes place in uncomplicated
pregnancies is exacerbated (Hauguel-de Mouzon & GuerreMillo 2006). The overexpression of pro-inflammatory
cytokines contributes to excessive peripheral insulin
resistance in the mother, necessitating enhanced insulin
secretion to maintain euglycemia, which is often not
met in GDM pregnancies (Lappas et al. 2005). Thus, it
is plausible that a prolonged low-grade inflammatory
environment persisting after parturition in the absence of
the placenta could result from cytokines released by other
organs, such as adipose tissue, which could contribute to
β-cell dysfunction postpartum and lead to dysglycemia.
Inflammation can contribute to β-cell dysfunction (Chen
et al. 2015) via endoplasmic reticular stress resulting in
decreased insulin sensitivity, as has been documented in
GDM patients (Catalano 2014).
We investigated the changes that occur in mouse
pancreas during pregnancy and found a three-fold
increase in BCM on GD18, resulting largely from increased
β-cell replication which peaked at GD12 (Beamish et al.
2017, Szlapinski et al. 2019). In our previous experiments,
female offspring of mice fed a low protein (LP) diet
during gestation and lactation were glucose intolerant
at GD18 during their own pregnancy when compared to
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offspring from control diet-fed mothers (Szlapinski et al.
2019). Glucose intolerance was associated with reduced
β-cell proliferation leading to a lower BCM, in addition
to reduced glucose-stimulated insulin secretion (GSIS).
Since GDM increases the risk of the mother developing
subsequent T2DM, we have used the previously mentioned
mouse model of gestational glucose intolerance to follow
animals after parturition and determine whether glucose
tolerance normalizes postpartum and what the longterm effects of glucose intolerance during pregnancy are
on maternal pancreas morphometry. The mechanisms
contributing to adaptive BCM expansion during pregnancy
in rodents have been extensively studied. However, few
studies exist investigating changes that occur past 7–10
days postpartum, and to our knowledge no data exists
comparing pancreas morphometry after hyperglycemic
and control pregnancy. We aimed to determine: (1)
what happens to glucose tolerance and islet morphology
postpartum after a normal vs a hyperglycemic pregnancy
and (2) the possible involvement of cytokines and PD-L1
in long-term changes in islet morphology and glucose
tolerance postpartum.

Materials and methods
Animals and sample collection
Adult (6-week-old) C57BL/6 male and female mice
(Charles River) were housed in a temperature-controlled
room with 12 h light:12 h darkness cycle at Lawson
Health Research Institute (London, ON, Canada). Water
and food were given ad libitum. Mice showing gestational
glucose intolerance were generated using a previously
described protocol involving a dietary insult during
early life (Szlapinski et al. 2019). Briefly, timed pregnant
F0 females were randomly allocated to either a control
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(C, 20% protein; Bio-Serv, Frenchtown, NJ, USA) or
low protein diet (LP, 8%) group, where an increase
in carbohydrate in LP diet yields an isocalorific diet
compared to control chow. F0 dams were fed either the
LP or C diet throughout gestation and lactation. A total
of 12 LP and 12 C litters were used. On postnatal day
(PND) 21, female offspring (F1) were weaned onto C
diet for the remainder of the study (Fig. 1). At maturity
(PND42), female offspring (F1) of LP and C diet-fed
mothers were randomly allocated into two subsequent
study groups: pregnant (LPP, CP) or non-pregnant
(LPNP, CNP). All pregnant-grouped females were mated
with C diet-fed males, separated upon confirmation of
pregnancy by vaginal plug and housed individually for
the remainder of the experiment. Upon birth of pups,
CP and LPP females were randomly allocated to one
of three timepoints after parturition (postpartum day
(PPD) 7, PPD30, or PPD90). For consistency, pups from
all litters were euthanized at postnatal day 7. Mothers
(F1) were euthanized by CO2 asphyxia following an
intraperitoneal glucose tolerance test (IPGTT) on PPD7,
PPD30, or PPD90 for comparison to non-pregnant agematched F1 females. Data (histology and IPGTT) for nonpregnant and GD18 animals, except for in vivo serum
quantification, presented here have previously been
published and are being used as a comparison to novel
postpartum data in this study (Szlapinski et al. 2019).
Following the IPGTT, maternal (F1) blood was collected
via cardiac puncture in order to quantify serum insulin,
glucagon, and PD-L1 quantified using an Ultra Sensitive
Mouse Insulin ELISA kit (Crystal Chem, Downers Grove,
IL, USA), Mouse Glucagon ELISA kit (Crystal Chem), and
PD-L1 ELISA assay (LifeSpan Biosciences, Seattle, WA,
USA), respectively. Data were collected using a BioRad
iMark plate reader and analyzed using Microplate
Manager Software.

Figure 1
Experimental timeline for the generation of mice
with gestational glucose intolerance and
timepoints for sample collection. Female offspring
(F1) were exposed to the low protein (LP) or
control (C) diet during gestation and lactation and
weaned onto C diet. At maturity, F1 females were
mated with C-fed males. Pups (F2) from all litters
were euthanized at postnatal day 7. Stars
demonstrate timepoints where an intraperitoneal
glucose tolerance test was performed, the
pancreas was removed for histology (n = 4–7
animals for each group), and serum was collected
via cardiac puncture. A full color version of this
figure is available at https://doi.org/10.1530/
JOE-20-0012.
https://joe.bioscientifica.com
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Pancreata were removed immediately following
euthanasia and fixed in 4% paraformaldehyde for
histology (Electron Microscopy Sciences, Hatfield, PA,
USA). Fixed pancreas tissue was prepared and sectioned
as previously described (Beamish et al. 2016). At least two
7 μm-thick cryosections (replicates) were cut from each
pancreas with an interval between each section >100 μm
representing at least two longitudinal slices through the
pancreas. Sections included both the head and tail of
the pancreas. All animal procedures were approved by
the Animal Care Committee of Western University in
accordance with the guidelines of the Canadian Council
for Animal Care.
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using the terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) assay.
Protein extraction and cytokine analysis
Posterior s.c. white adipose tissue (27–50 mg) was lysed
for 30 min in an ice-cold buffer as previously described
(de Castro et al. 2011). Cytokine levels in adipose tissue
protein extracts (n = 3–4 C and LP animals per timepoint,
PPD90 C n = 2) were determined by multiplexing in a
Bioplex system using customized kits from R&D systems
(Magnetic Luminex assay) for cytokines of interest
(TNF-α, IL-6, IL-1β, and IFNγ). Values were normalized to
weight of sample.

Glucose tolerance tests
An IPGTT was performed on all animals prior to
euthanasia, as previously described (Chamson-Reig et al.
2009), at the assigned day postpartum or age for the agematched group (n = 4–7 C and LP animals per timepoint).
Mice were fasted for 4 h with free access to water, injected
intraperitoneally with 5 μL/g body weight of 40% glucose
solution (2 g/kg body weight glucose, Sigma Aldrich), and
blood glucose measured from the tail at 0, 5, 15, 30, 60,
90, and 120 min using a One Touch Ultra2 glucometer.
Immunohistochemistry and morphometric analysis
Fluorescence immunohistochemistry was performed
to localize insulin (β-cells) and glucagon (α-cells) for
morphometric analysis as previously described (Szlapinski
et al. 2019). Every insulin and glucagon-expressing cell
was imaged at 20× with the observer being blind to tissue
identity using a Nikon Eclipse TS2R inverted microscope
with NIS-Elements. The microscope was equipped with an
LED light source with emission bandwidths set to 460/50 nm
for blue emission, 535/50 nm for green emission, and
590/40 nm for red emission. For morphometric analyses,
manual tracing of all islets for the tissue section was
completed using ImageJ to quantitate fractional α- and
β-cell area (sum of all glucagon or insulin-expressing
areas divided by the whole pancreas surface area).
Fractional areas were calculated from at least two sections
(replicates) per pancreas (n = 4–6 C and LP animals per
timepoint). Islets were counted per tissue section and
further separated by size into small (<5000 μm2), medium
(5000–10,000 μm2), or large (>10,000 μm2) islets as
previously described (Chamson-Reig et al. 2006). ApopTag
Plus In Situ Apoptosis Fluorescein Detection Kit (S7111,
EMD Millipore) was used to identify apoptotic β-cells
https://joe.bioscientifica.com
https://doi.org/10.1530/JOE-20-0012
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Statistical analysis
Data are presented as mean ± s.e.m., with statistics analyzed
using GraphPad Prism (version 5.0). To determine effects
of pregnancy on pancreas morphometry postpartum (CP),
a one-way ANOVA was used followed by Bonferroni’s
post-hoc test. For comparisons of LPP and CP groups
over time, a two-way ANOVA followed by Bonferroni’s
post-hoc test was used. A repeated measures two-way
ANOVA followed by Bonferroni’s post-hoc test was used
for comparison of the IPGTT curves between treatment
groups (LP vs C) at each timepoint after parturition.
An unpaired two-tailed Student’s t-test was used for
comparison of IL-6 levels at PPD7 between dietary
groups. Each animal presented as a single unit of analysis
(n). Only the postpartum timepoints were included in
statistical analyses to present novel data. To account for
differences in litter sizes, the mean litter size for LPP and
CP groups was determined. Litter sizes that were more
than two standard deviations greater than the mean were
considered outliers. This did not result in any outliers
in the data set. Statistical significance was determined
as P < 0.05.

Results
Mice with gestational glucose intolerance display
altered pregnancy characteristics
Offspring born to dams fed a LP diet during gestation and
lactation (F1, LPP) weighed less than controls (F1, CP)
throughout gestation (Fig. 2A) and gained significantly
less weight than CP females at GD17 and 19 (Fig. 2B).
There were no significant differences in body weight
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Figure 2
Mice with gestational glucose intolerance display
altered pregnancy characteristics. (A) Pregnant
female mice born to dams fed a low protein diet
(LPP) weighed less and (B) gained less weight than
pregnant female mice born to dams fed a control
diet (CP) throughout pregnancy (n = 7 CP females,
n = 10 LPP females). (C) No differences in body
weight were found after parturition between
dietary groups (n = 4–6 CP and LPP females).
***P < 0.001, **P < 0.01.

between dietary groups after parturition (Fig. 2C). Body
weight differed with time after parturition in both dietary
groups (P < 0.01, Fig. 2C).
Mice with gestational glucose intolerance demonstrate
prolonged glucose intolerance after parturition
We compared glucose tolerance in LPP vs CP mice after
parturition. LPP females that were relatively glucose
intolerant at GD18 continued to display glucose
intolerance at PPD7 with higher blood glucose levels
at 15 and 30 min into an IPGTT (Fig. 3A). The relative
glucose intolerance persisted at 1 month postpartum
(PPD30, Fig. 3B). However, by 3 months postpartum
(PPD90, Fig. 3C) LPP females had a similar glycemic profile

Figure 3
LPP females show prolonged glucose intolerance after parturition.
Pregnant female mice born to dams fed a low protein diet (LPP) show
glucose intolerance relative to pregnant female mice born to dams fed a
control diet (CP) at (A) postpartum day 7 (PPD7, n = 6 CP females, 7 LPP
females) and continue to be glucose intolerant at (B) 1 month postpartum
(PPD30, n = 6 CP females, 5 LPP females). (C) However, by 3 months
postpartum (n = 4 CP females, 4 LPP females) LPP females display a
glycemic profile similar to that of a control and demonstrate a similar
glycemic profile to that of a (D) non-pregnant animal (n = 6 C nonpregnant females, 5 LP non-pregnant females). ***P < 0.001, **P < 0.01,
*P < 0.05.
https://joe.bioscientifica.com
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as that seen in controls. Furthermore, the glycemic profile
at PPD90 was restored to that of a non-pregnant animal
(Fig. 3D). There were no significant differences in fasting
blood glucose levels between dietary groups or with time
(Supplementary Fig. 1A, see section on supplementary
materials given at the end of this article). Additionally,
area under the glucose tolerance curve was higher in
the LPP group at PPD7 compared to controls
(Supplementary Fig. 1B).
Pregnancy alters pancreas morphology postpartum
after both control and hyperglycemic pregnancies
We investigated how endocrine pancreas morphology
changed after parturition, both in CP and LPP groups.
Pancreatic sections were immunostained for insulin
(β-cells) and glucagon (α-cells) for morphometric
analyses (Fig. 4). Since pancreas weight was relatively
higher in the LPP group at PPD30 and PPD90 (Fig. 5A),

Figure 4
Representative immunofluorescent images demonstrating β- (insulin, red)
and α-cells (glucagon, green) in pregnant female mice born to dams fed a
control diet (CP) and pregnant female mice born to dams fed a low
protein diet (LPP) at postpartum days (PPD) 7 and PPD90. Nuclei were
counterstained with DAPI (blue). Scale bar represents 25 microns.
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Figure 5
Pregnancy alters pancreas morphology
postpartum after control and hyperglycemic
pregnancies. (A) Pancreas weight was higher in
pregnant female mice born to dams fed a low
protein diet (LPP) at postpartum day (PPD) 30 and
PPD90 relative to pregnant female mice born to
dams fed a control diet (CP). Both the fractional
(B) β-cell area and (C) α-cell area were lower in LPP
animals vs controls at PPD7. Furthermore, α-cell
area was lower at PPD30 vs PPD7 in CP females.
(D) Alpha to β-cell ratio did not differ between
dietary groups or timepoints after parturition
(n = 4–6 CP and LPP females). ***P < 0.001,
*P < 0.05.

β/α-cell fractional areas were used for histological
analyses rather than BCM. Beta-cell fractional area was
lower in LPP animals compared to CP animals at PPD7
(Fig. 5B). Notably, relative to PPD7, CP females had a
~30% reduction in β-cell fractional area at PPD30 and a
~40% reduction by PPD90 (Fig. 5B), the latter resulting
in a β-cell fractional area comparable to a non-pregnant
animal. In contrast to CP females, β-cell fractional area
did not further decrease postpartum in the LPP group,
rather the values remained at a similar level from GD18
up until PPD90 (Fig. 5B). Alpha-cell fractional area was
Table 1

Islet size distributions are altered postpartum after control and hyperglycemic pregnancies in mice.

Timepoint

Treatment

Non-pregnant

Control
LP
CP
LPP
CP
LPP
CP
LPP
CP
LPP

GD18
PPD7
PPD30
PPD90

lower in LPP animals compared to CP at PPD7 (Fig. 5C).
Furthermore, α-cell area was lower at PPD30 vs PPD7
in CP females. There were no significant differences in
the α- to β-cell ratio (Fig. 5D) between dietary groups or
with time after parturition. No evidence of dual-stained
insulin/TUNEL cells was found when investigating the
contribution of β-cell apoptosis at PPD7.
Islet quantification demonstrated that the number of
small, medium, and large-sized islets varied with time after
parturition (Table 1). At PPD90, there were significantly
more small-sized islets in the LPP females compared to

Small (5000 μm2)

Medium (5000–10,000 μm2)

Large (10,000 μm2)

Mean islet size (µm2)

9.64
7.50
17.88
7.90
13.92
11.80
17.20
13.73
5.29
12.29a

1.79
1.42
3.00
1.30
2.50
1.30
4.50
2.63
1.50
2.00

2.00
1.33
5.00
1.60
3.83
1.80
6.70
4.00
2.13
2.00

4974
4076
7967
4324
6394
3599
6141
5390
6403
6373

The number of small, medium, and large-sized islets varied with time after parturition in both dietary groups (P < 0.05). There were more small islets at
postpartum day (PPD) 90 in pregnant female mice born to dams fed a low protein diet (LPP) compared to pregnant female mice born to dams fed a
control diet (CP). There were no significant differences in mean islet size after parturition between dietary groups.
aP < 0.05 LPP vs CP.
https://joe.bioscientifica.com
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controls (Table 1). There were no significant differences
in mean islet size after parturition between dietary groups
(Table 1). However, the mean islet size was 1.8-fold
higher at PPD90 (6373 ± 2065 μm2) compared to PPD7
(3599 ± 452 μm2) in the LPP group (P = 0.147, Table 1).

Cytokines may contribute to glucose intolerance
after parturition in mice experiencing hyperglycemic
pregnancies
To investigate a potential contribution to prolonged
glucose intolerance after parturition in the LPP group,
we measured levels of representative cytokines in adipose
tissue extracts by determining levels of TNF-α, IL-6, IL-1β,
and IFNγ. TNF-α levels varied with time after parturition in
both dietary groups and were 1.4-fold higher in the LPP
group at PPD7 compared to controls (3.56 ± 1.10 pg/mL/mg
tissue vs 2.55 ± 0.98 pg/mL/mg tissue, P = 0.534, Fig. 6A).
Levels of IL-6 were higher in the LPP group at PPD7
compared to controls (Fig. 6B). There were no significant
differences in levels of IL-1β with time after parturition
or between dietary groups (Fig. 6C). However, IL-1β was
1.4-fold higher at PPD7 in LPP compared to controls
(698.5 ± 254.7 pg/mL/mg tissue vs 517.8 ± 274.2 pg/mL/mg
tissue, P = 0.654, Fig. 6C). Levels of IFNγ were 3.1fold higher at PPD7 in LPP compared to controls
(68.63 ± 24.94 pg/mL/mg tissue vs 21.88 ± 4.51 pg/mL/mg
tissue, P = 0.139, (Fig. 6D).
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Next, circulating levels of PD-L1, insulin, and
glucagon in serum were quantified. There were no
significant differences in levels of PD-L1 between
dietary groups. However, values differed with time after
parturition, as levels of PD-L1 were higher at PPD90
compared to PPD7 in controls, but not in LPP mice (Fig.
7A). Of note, there was also a 2.7-fold higher amount
of PD-L1 present in LPP animals at PPD7 compared to
controls (145 ± 50 pg/mL vs 55 ± 29 pg/mL, P = 0.214,
Fig. 7A). The ratio of serum insulin to glucagon varied
with time after parturition in both CP and LPP mice (Fig.
7B), with a trend toward a higher ratio in the LPP group
(P = 0.071 LP vs C, Fig. 7B).

Discussion
GDM increases the subsequent risk of maternal
dysglycemia or T2DM by up to 7-fold (Melchior et al. 2017),
although the relationship of this risk to longstanding
changes in β-cell histology postpartum is unknown.
Using a mouse model of gestational glucose intolerance,
we addressed this knowledge gap by showing that dams
continue to show glucose intolerance for at least a month
after parturition (PPD30), and that glycemic control
did not normalize until 3 months postpartum (PPD90).
This persistent glucose intolerance was associated with
lower β- and α-cell fractional areas at PPD7 compared
with control pregnancies representing an extension of the

Figure 6
Altered cytokines may contribute to glucose
intolerance in hyperglycemic mice after
parturition. Adipose tissue content of: (A) TNF-α,
(B) IL-6, (C) IL-1β, and (D) IFNγ for pregnant female
mice born to dams fed a control diet (CP) and
pregnant female mice born to dams fed a low
protein diet (LPP) at postpartum days (PPD) 7, 30,
and 90. (A) TNF-α content significantly increased
with time postpartum but not between dietary
groups. (B) IL-6 content decreased with time but
was significantly higher in LPP animals. (C) IL-1β
and (D) IFNγ content did not differ with time or
between diets. n = 3–4, **P < 0.01, *P < 0.05.
https://joe.bioscientifica.com
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Figure 7
Pregnancy results in long-term alterations in serum levels of PD-L1,
insulin, and glucagon after parturition. Serum levels of (A) PD-L1 and (B)
insulin:glucagon ratio. (A) PD-L1 levels increased with time in pregnant
female mice born to dams fed a control diet (CP) but not in pregnant
female mice born to dams fed a low protein diet (LPP). (B) The serum
insulin:glucagon ratio trended to be higher in LPP animals compared to
controls (P = 0.0705) and varied with time in both groups. n = 3–5,
***P < 0.001, *P < 0.05.

relative differences seen in late pregnancy for the glucoseintolerant dams.
Several studies have reported the presence of β-cell
dysfunction postpartum clinically after GDM (Buchanan
& Xiang 2005, Retnakaran et al. 2008, Xiang et al. 2010,
Molęda et al. 2013). Progressive β-cell dysfunction is likely
the predominant factor that drives the transition from
impaired glucose tolerance to T2DM after GDM (Bellamy
et al. 2009, Saisho et al. 2013). In this study, LPP animals
displayed glucose intolerance at PPD7 and PPD30 relative
to controls. We have previously shown that LPP animals
exhibit β-cell dysfunction at late gestation (GD18),
resulting in reduced GSIS (Szlapinski et al. 2019). A previous
clinical study classified β-cell dysfunction as the key factor
in the development of postpartum dysglycemia among
non-obese patients (Li et al. 2014); insulin resistance,
however, was determined to be the driver of postpartum
hyperglycemia in obese patients. Our animal model of
gestational glucose intolerance, which represents the nonobese category, therefore accurately reflects the changes
that occur during β-cell dysfunction after GDM, rather
than another underlying cause (such as insulin resistance
https://joe.bioscientifica.com
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as seen in obese patients). Although pre-gestational
obesity is a major driver of GDM, 20–30% of women that
develop GDM do not fall into this category. Therefore,
this implicates dysfunction at the level of the β-cell to
GDM pathophysiology (Petra et al. 2019). This study
thus proves useful for revealing underlying mechanisms
of glucose intolerance postpartum characterized by β-cell
dysfunction. Since the animal model represents only a
mild hyperglycemia, the animals in this study were able
to normalize blood glucose levels by PPD90. Nonetheless,
it is plausible that additional metabolic stress such as a
second pregnancy, or an age-related decline in β-cell
function (Westacott et al. 2017), could precipitate T2DM.
Human studies of impaired glucose tolerance
postpartum do not allow visualization of histological
changes occurring in endocrine pancreas. Previous studies
of healthy rodent pregnancy (Rieck & Kaestner 2010,
Beamish et al. 2017) report that offspring born to dams fed
a control diet (CP) had a ~50% reduction in BCM at PPD7
compared to GD18. In this study, CP females had a ~30%
reduction in β-cell fractional area at PPD30 compared
to PPD7 and ~40% by PPD90 relative to PPD7, reducing
β-cell fractional area to a level comparable to a nonpregnant animal. These differences could be attributed to
the use of fractional area in this study instead of BCM.
We used fractional area to exclude the effect of changes
in exocrine tissue mass postpartum. Prolactin can alter
exocrine tissue mass during lactation in mice (Matsuda
et al. 1994), and we found differences in pancreatic weight
postpartum in LPP mice. Thus, the use of fractional area
provides a more accurate representation of endocrine
changes in this study. These data support previous
findings that β-cell apoptosis is occurring in controls after
parturition in order to facilitate normalisation of BCM.
This occurs, in part, due to a switch of β-cell serotonin
receptor expression from HTR2B to HTR1D, mediating an
inhibitory signal and promoting regression of BCM via
increased β-cell apoptosis (Scaglia et al. 1995, Kim et al.
2010), in addition to higher levels of steroid hormones
at late gestation which block lactogen-induced β-cell
replication (Sorenson et al. 1993). Insulin/TUNEL staining
was negative when investigating the contribution of β-cell
apoptosis at PPD7, suggesting that the apoptotic processes
likely occur earlier postpartum since BCM was already
reduced by PPD7. Nonetheless, a potential explanation
for the retained β-cell fractional area at PPD7 in controls
could be due to persistently higher expression of serotonin
synthetic enzyme tryptophan hydroxylase-1, Tph1, which
normally increases during pregnancy in β-cells in order
to mediate BCM expansion. A previous study found that
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Tph1 expression remained high at PPD7 until the end of
lactation (PPD21) when levels returned to pre-pregnancy
levels (Kim et al. 2010).
In terms of changes in pancreatic α-cell abundance,
fractional area was lower at PPD30 compared to PPD7 in CP
females. Thus, it is evident that there is a prolonged effect
of pregnancy on the ontogeny of α-cells, as fractional area
decreases to a level lower than the non-pregnant control
at PPD90. These findings prompt interesting questions for
future studies, especially concerning a second pregnancy
and whether the pool of α-cells would increase and expand
as observed on GD18 in a healthy pregnancy? (QuesadaCandela et al. 2019, Szlapinski et al. 2019). Furthermore,
would the pool of α-cells take longer to replenish or is the
α-cell complement fully depleted after a first pregnancy?
In contrast to CP females, β-cell fractional area
was not further decreased postpartum in LPP mice; the
values instead remained at a similar level from GD18 to
PPD90. There were no differences in β-cell proliferation
between dietary groups at PPD7 compared to nonpregnant animals (Supplementary Fig. 1C). These data
confirm previous findings that lactogen-induced β-cell
proliferation that normally occurs during pregnancy,
which is also functionally linked to increased levels
of progesterone and estradiol as pregnancy progresses
(Sorenson et al. 1993), is arrested by PPD7. However, since
levels of β-cell replication were comparable in CP and LPP
groups postpartum, this excludes β-cell replication as a
mechanism for the sustained elevated fractional β-cell in
LPP mice. As previously mentioned, we found no evidence
of β-cell apoptosis at PPD7. These findings support clinical
data that markers of β-cell loss were reduced in serum
samples from women postpartum after GDM and reached
levels seen in non-pregnant women (Kenna et al. 2016).
Thus, our study is the first to provide histological evidence
to support these clinical findings by demonstrating that
less β-cell loss is occurring postpartum after mild GDM.
When comparing healthy and hyperglycemic
pregnancies, both α- and β-cell fractional areas were lower
in LPP mice at PPD7; a likely result of the insufficient
endocrine pancreas adaptation previously found to occur
at GD18, appearing to persist at PPD7. Importantly, α-cells
have been identified as a target for serotonin action, as a
study in human islets showed that β-cell-derived serotonin
inhibited glucagon secretion in response to high glucose
(Almaça et al. 2016). Due to a reduced fractional β-cell area
in LPP animals at PPD7 in this study, it is plausible that
α-cells receive a reduced serotonergic input from β-cells
and thus lose their ability to regulate glucagon secretion.
This may result in uncontrolled glucagon secretion and
https://joe.bioscientifica.com
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could contribute to the hyperglycemia seen in LPP animals
at PPD7. This was shown to occur in vivo in women with
GDM through a lack of suppression of plasma glucagon
at late pregnancy that persisted postpartum (Beis et al.
2005). These findings highlight an important role for
pancreatic α-cells in pregnancy which has previously been
overlooked.
Despite the lack of a placental hormone stimulus
to endocrine cell expansion postnatally, the β-cell
fractional area did not change in LPP mice. This might
be a compensatory mechanism in attempt to attain
euglycemia. Size stratification of islets varied at PPD7 and
PPD30 in both control and LP groups, but there were no
differences between dietary groups. This suggests that
pregnancy itself causes re-modeling of islet populations
after parturition. Additionally, there were more small islets
in LPP females compared to controls found at PPD90,
contributing to a recovered mean islet size comparable to
that of a control. Thus, these data support an additional
adaptive response in endocrine cells postpartum in LPP
animals. These data could implicate β-cell neogenesis of
small islets to facilitate normalization of mean islet size at
PPD90 as a compensatory mechanism, thereby resulting
in a rescue of glucose tolerance relative to controls.
The LPP group had a higher ratio of insulin relative to
glucagon after parturition compared to controls, which
provides further support of such an adaptive response.
Pro-inflammatory cytokines can modify insulin
signaling pathways and can lead to β-cell dysfunction (Kolb
& Mandrup-Poulsen 2005). Consequently, overexpression
of cytokines can accelerate inflammation and exacerbate
insulin resistance. Women with GDM have been shown to
have increased circulating levels of the pro-inflammatory
cytokines TNF-α, IL-1β, and IL-6, all of which are associated
with β-cell dysfunction (Yang et al. 2018, Petra et al. 2019).
Thus, it is plausible that prolonged glucose intolerance or
T2DM after GDM could involve persistent inflammation
postpartum. Both mouse and human placenta express
multiple cytokines that contribute to the state of insulin
resistance that occurs during pregnancy; for instance,
TNF-α induces IRS-1 serine phosphorylation, which
contributes to BCM expansion and insulin resistance in
pregnancy (Kirwan et al. 2002, Barbour et al. 2007). In
women with GDM, the decrease in insulin receptor tyrosine
kinase phosphorylation does not improve postpartum as
it does in women following a healthy pregnancy (Kirwan
et al. 2004, Catalano 2014). In the present model, levels of
TNF-α were relatively higher in the LPP animals compared
to controls after parturition which could contribute, in
part, to the glucose intolerance seen at PPD7 and PPD30.
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TNF-α levels in adipose increased with time, as seen in
non-obese women in a study investigating longitudinal
changes in serum pro-inflammatory markers across
pregnancy and postpartum (Christian & Porter 2014).
IL-6 has been found to be significantly higher in women
with GDM, independent of adiposity (Mirghani Dirar &
Doupis 2017), as observed in adipose samples from the
non-obese animals used in this study where levels of IL-6
were higher in LPP mice at PPD7 compared to controls.
Interestingly, IL-6 levels were reduced in both CP and
LPP groups by PPD90, concomitant with the return of
glucose tolerance to control values. Some studies have
found that high concentrations of IL-6 could promote
β-cell apoptosis and contribute to glucose intolerance (Jin
et al. 2016). However, since β-cell area did not change at
any time point after parturition in LPP mice, it is more
likely that IL-6 is exerting effects on non-islet tissues.
IL-6 has been shown to increase lipolysis in adipocytes,
damage mitochondria and GLUT2 function, and as a
result decrease insulin sensitivity (Dessein et al. 2002).
It is reasonable that higher IL-6 tissue levels contibuted
to increased insulin resistance postpartum in LPP mice
(Barbour et al. 2007). IL-6 can also induce production of
IL-1β and TNF-α (Calabrese & Rose-John 2014), further
intensifying levels of pro-inflammatory cytokines
postpartum and contributing to β-cell dysfunction and
glucose intolerance. However, IL-1β levels in adipose
tissue did not differ between dietary groups in the present
studies. Collectively, these findings implicate a potential
contribution of inflammation to insulin resistance
postpartum in LPP mice, resulting in a maintaned β-cell
area resistant to apoptosis postpartum.
An increase in cytokine production occurs in healthy
pregnancies. However, the activity of PD-L1 also increases
and attenuates the low-grade inflammatory immune
response (Meggyes et al. 2019), potentially protecting
maternal β-cells from cytotoxic damage. In the present
study, levels of PD-L1 were relatively higher in LPP mice
at PPD7 compared to controls. This may have helped to
enhance β-cell survival in the face of a higher cytokine
environment, as has been observed in autoimmune
diabetes in NOD mice (Wang et al. 2008). The PD-L1
ligand has also been shown to be expressed in β-cells of
individuals with type 1 diabetes as a possible attempt to
attenuate autoimmune attack (Colli et al. 2018). However,
PD-L1 was absent from islets of non-diabetic controls.
Furthermore, the same study showed that IFNγ induced
PD-L1 mRNA expression in human pancreatic β-cells
in vitro, potentially implicating IFNγ at PPD7 in LPP
mice in this study as a mechanism for increasing PD-L1
https://joe.bioscientifica.com
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levels. This pathway might also mediate β-cell neogenesis
leading to a subsequent increase in the number of small
islets observed at PPD90. This inflammatory pathway may
also explain why β-cell fractional area remained elevated
in LPP mice postpartum. Follow-up experiments treating
LPP and CP mice at PPD7/30/90 with a PD-L1 inhibitor
would be insightful to investigate potential differences
in the ratio of serum insulin to glucagon. Interestingly,
PD-L1 levels increased from PPD7 to PPD90 in controls.
As a multitude of immunological changes involving
both pro- and anti-inflmamatory cytokines are occuring
throughout pregnancy to the postpartum period, it is
plasuble that serum PD-L1 levels were elevated in controls,
in part, to suppress maternal immunity or to mediate a
protective effect on β-cells against higher levels of TNF-α
at postpartum. Interestingly, since PD-L1 levels were
~25% lower in LPP mice at PPD90, perhaps these animals
will be more prone to cytoxicic β-cell damage and could
be on the trajectory to dysglycemia or T2DM. PD-L1 has
also been identified as a biomarker for GDM in humans
(Ye et al. 2017) and our findings support a potential role
as a marker for prolonged glucose intolerance after GDM.
In summary, we present novel findings of the
ontogeny of α- and β-cell fractional areas of islet
morphology and glucose tolerance postpartum in normal
and hyperglycemic mouse pregnancies. The results
demonstrate long-term pancreatic re-modeling after
parturition involving both pancreatic α- and β-cells, which
was associated with changes in the pro-inflammatory
environment. These findings are informative in
understanding the pathophysiology involved in the
progression from GDM to glucose intolerance and T2DM.
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